CMS Seeking To Incentivize Registry Participation With Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
CMS is considering making participation in certain post-market registries a condition for medical centers to receive Medicare reimbursement, according to Coverage & Analysis Group Director Steve Phurrough
You may also be interested in...
Thoratec HeartMate Gradual Roll-Out, Center Criteria Counseled By MCAC
Thoratec expects the Centers for Medicare & Medicaid Services to announce plans for national coverage of the HeartMate VE left ventricular assist device as a destination therapy by June
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.